Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NH/Manchester
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Manchester, NH

Studies commonly pay $75 to $4,500 per completed study

85 clinical trials are currently recruiting participants within 30 miles of Manchester. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

85studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Manchester right now

Top 25 of 85 recruiting studies, sorted by proximity — each links to its official registry page

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Elliot Hospital — Manchester, New Hampshire (0.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Phase 2 Interventional 474 participants sought
Dana Farber-Merrimack Valley — Methuen, Massachusetts (22.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632977)

Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease

Dry Eye Disease (DED) Phase 4 Interventional 60 participants sought
Andover Eye Associates — Andover, Massachusetts (27.4 mi) · Sponsor: Andover Research Eye Institute
See eligibility & contact on ClinicalTrials.gov (NCT07676084)

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Osteoarthritis, Knee, Diabetic Neuropathic Pain Phase 2 Interventional 10,000 participants sought
ActivMed Practices and Research — Methuen, Massachusetts (22.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT05986292)

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Metastatic Non-small Cell Lung Cancer With MTAP Deletion Phase 2, Phase 3 Interventional 590 participants sought
Local Institution - 0600 — Manchester, New Hampshire (0.9 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07063745)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
CRO Call Center — Methuen, Massachusetts (22.0 mi) · Sponsor: Retension Pharmaceuticals. Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07142356)

Assessment of CCM in HF With Higher Ejection Fraction

Heart Failure, Heart Failure With Preserved Ejection Fraction N/A Interventional 1,500 participants sought
Catholic Medical Center — Manchester, New Hampshire (0.9 mi) · Sponsor: Impulse Dynamics
See eligibility & contact on ClinicalTrials.gov (NCT05064709)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 626 participants sought
Dana-Farber Cancer Institute - Merrimack Valley — Methuen, Massachusetts (22.0 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04613596)

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Growth Hormone Deficiency N/A Observational 500 participants sought
Ascendis Investigational Site — Manchester, New Hampshire (0.9 mi) · Sponsor: Ascendis Pharma Endocrinology Division A/S
See eligibility & contact on ClinicalTrials.gov (NCT05775523)

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation N/A Observational 538 participants sought
Lowell General Hosptial — Lowell, Massachusetts (25.1 mi) · Sponsor: PrECOG, LLC.
See eligibility & contact on ClinicalTrials.gov (NCT06538038)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Dartmouth Cancer Center - Manchester/ DCC Manchester — Manchester, New Hampshire (0.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Alzheimer Disease Phase 4 Interventional 150 participants sought
ActivMed Practices & Research, LLC — Methuen, Massachusetts (22.0 mi) · Sponsor: Alpha Cognition, Inc
See eligibility & contact on ClinicalTrials.gov (NCT07633470)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Exeter Hospital — Exeter, New Hampshire (25.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 117 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT07393555)

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Heart Failure With Preserved Ejection Fraction Phase 3 Interventional 2,000 participants sought
Pentucket Medical Associates — Haverhill, Massachusetts (23.5 mi) · Sponsor: Uppsala University
See eligibility & contact on ClinicalTrials.gov (NCT02901184)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes N/A Observational 10,000 participants sought
Dana Farber/New Hampshire Oncology-Hematology — Londonderry, New Hampshire (9.0 mi) · Sponsor: Dana-Farber Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT02269592)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06876714)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05812807)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Major Depressive Disorder Phase 3 Interventional 450 participants sought
Activmed Practices & Research, Llc - Methuen — Methuen, Massachusetts (22.0 mi) · Sponsor: Xenon Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07076407)
Actively enrolling

Studies you may be able to join near Manchester

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Manchester

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Advanced Regenerative Manufacturing Institute (ARMI) / BioFabUSA

★ 3.2
Technology Center, University Center, 400 N Commercial St, Manchester, NH 03101
(603) 666-3905
"I'm just curious if any regular patients have had a new kidney from them, yet??? Anybody?? Because people NEED kidneys the most so what's the prognos…"
— A Google User, 2★

Dartmouth Cancer Center Manchester | Head & Neck Cancer Program

87 McGregor St, Manchester, NH 03102
(603) 629-1828

Tellica Imaging - Manchester

★ 5.0
1100 Bicentennial Dr Unit B-3, Manchester, NH 03104
(603) 782-4303
"Cat scan done by Lynn and MRI done by Wayne, several days apart. Both terrically well done."
— John Scheide, 5★

Clinical Trials of New England

1234 Hyde Park Ave #205, Hyde Park, MA 02136

ActivMed Practices & Research, LLC

★ 4.6
421 Merrimack St #203, Methuen, MA 01844
(978) 655-7155
"This office is great. I have volunteered for a few studies at other labs, but I like this the one the best so far."
— Robert Grant, 5★

Innovative Psychiatry Center

★ 4.8 (75 reviews)
258 S River Rd, Bedford, NH 03110
(603) 758-3192
"My psychiatrist is very helpful and easy to talk to."
— T W, 5★

BMC Clinical Research Unit

850 Harrison Ave 6th floor, Boston, MA 02118
(617) 638-8855

Boston Clinical Trials

★ 4.4
26 Cummins Hwy, Boston, MA 02131
(617) 477-4868
"Very well organized and telephone health checks were very helpful in getting a good sample collection. Would do this again if offered."
— Mary Wolfe, 5★

St. Joseph Hospital Family Medicine & Specialty Services - Merrimack

★ 4.8
4 Dobson Way, Merrimack, NH 03054
(603) 424-4181
"I’ve been a patient of Cathy ODonnell for over 20years. She is easy to talk to and very thorough and knowledgeable about women’s health."
— Nina Raymond, 5★

Clinical trials in Manchester: what's recruiting

The Manchester area currently has 85 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Manchester, the most active research areas are:

  • Cancer & Oncology13 studies
  • Heart & Vascular3 studies
  • Brain & Mental Health2 studies
  • Diabetes & Metabolism1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Manchester, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Manchester

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Manchester participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Manchester safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Manchester, NH?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Manchester?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Manchester?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Manchester.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Manchester typically complete one or two studies per year.

Paid clinical trials near Manchester

Other metros within reach

Nashua, NH269 Boston, MA2,976 Worcester, MA274 Providence, RI553 Portland, ME162 Springfield, MA308 New Bedford, MA514 Norwich, CT125

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Manchester Bladder Issues Due To Spinal Cord Injury in Manchester All conditions

More of NH

Nashua269

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts